The mission of Alzheimer's & Dementia: Journal of the Alzheimer's Association is to bridge the knowledge gaps across a wide range of bench-to-bedside investigation. The journal publishes the results of studies in: behavior, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health services research, health economics, political science and public policy. Content emphasizes interdisciplinary investigations, integrative/translational articles, related to: etiology, risk factors, early detection, disease modifying interventions, prevention of dementia and applications of new technologies in health services.

The ultimate objective is to create a novel forum for:

rapid communication of new findings, ideas or perspectives;
disseminating knowledge, across the spectrum of basic to clinical studies, necessary for optimal translation of research findings into practical applications/interventions;
integrating knowledge across disciplines;
increase knowledge in diverse disciplines to promote early detection/diagnosis and/or interventions;
formulating new theories and/or strategies for the rigorous testing of theories or their predictions;
identifying promising new directions of research;
providing the scientific impetus for new initiatives; and
public policies concerning research on prevention and new models of health services.
Alzheimer's & Dementia is indexed/abstracted in Index Medicus/MEDLINE, Scopus, Science Citation Index Expanded (SciSearch®), Current Contents®/Clinical Medicine, Neuroscience Citation Index®, and Journal Citation Reports/Science Edition.

comprehensive reviews;
research articles;
information on clinical trials;
short reports;
in-depth perspectives/open-peer commentaries;
theoretical and/or translational papers that attempt integrate knowledge across discipline;
history & politics of science/brief biographies;
abstracts of papers presented at international meetings; 
negative results, particularly clinical trials, as short communications.